Your institution may have access to this item. Find your institution then sign in to continue.
Title
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
Authors
Hanauer, Stephen B; Feagan, Brian G; Lichtenstein, Gary R; Mayer, Lloyd F; Schreiber, S; Colombel, Jean Frederic; Rachmilewitz, Daniel; Wolf, Douglas C; Olson, Allan; Bao, Weihang; Rutgeerts, Paul; ACCENT I Study Group
Abstract
We did a randomised controlled trial to assess the benefit of maintenance infliximab therapy in patients with active Crohn's disease who respond to a single infusion of infliximab.